Perindopril

培哚普利
Mechanism of action:
Perindopril 是一種血管張力素轉化酶抑制劑(angiotensin-converting enzyme inhibitor),屬於二肽類(dipeptide)前驅藥。Perindopril 在體內被轉化為具有活性的 perindoprilat。Perindoprilat 能抑制血管張力素轉化酶(angiotensin-converting enzyme)將血管張力素 I(angiotensin I)轉化為血管張力素 II(angiotensin II),使週邊血管阻力下降、血壓降低。
Reference(s):
1. Hurst M et al. (2001). Perindopril: an updated review of its use in hypertension. Drugs.
2. Jastrzebskal M et al. (2004). Effects of perindopril treatment on hemostatic function in patients with essential hypertension in relation to angiotensin converting enzyme (ACE) and plasminogen activator inhibitor-1 (PAI-1) gene polymorphisms. Nutr Metab Cardiovasc Dis.
3. Parker E et al. (2005). The pharmacokinetics of perindoprilat in normal volunteers and patients: influence of age and disease state. Eur J Pharm Sci.
